<DOC>
	<DOCNO>NCT01072435</DOCNO>
	<brief_summary>Propofol drug choice deep sedation endoscopy . Propofol administer many way : infusion intravenous bolus self-administration device ( patient-controlled sedation ; PCS ) . It clear method propofol administration would preferable . The main objective trial compare 2 different method propofol administration ERCP : patient-controlled administration ( PCS ) target-controlled infusion ( TCI ) .</brief_summary>
	<brief_title>Target-controlled Infusion Versus Patient-controlled Sedation With Propofol Endoscopic Retrograde Cholangiopancreatography ( ERCP )</brief_title>
	<detailed_description>80 patient age 18-75 undergoing elective ERCP include randomize non-commercial clinical trial . Exclusion criterion : allergy opioids propofol , dementia , mental retardation , severe liver kidney insufficiency , significant heart failure lung disease , drug addiction . The endpoint : ease procedure performance , complication , degree sedation , recovery time , propofol opioid consumption . During procedure patient observe treated anaesthesiologist anaesthesia nurse .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>elective ERCP patient allergy propofol opioid ; inability cooperate ; ASA ( American Society Anaesthesiology ) class great 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>ERCP</keyword>
	<keyword>patient-controlled sedation</keyword>
	<keyword>target-controlled infusion</keyword>
	<keyword>propofol</keyword>
	<keyword>Sedation propofol ERCP</keyword>
	<keyword>Endoscopic Retrograde Cholangiopancreatography</keyword>
</DOC>